AbbVie Inc.
ABBVNYSE
Product information
What is AbbVie Inc. (ABBV)?
AbbVie Inc. is a US biopharmaceutical company based in North Chicago, Illinois. The company became independent in 2013 when it was separated from Abbott Laboratories; its shares trade on the NYSE under the ticker ABBV.
The center of gravity of its portfolio is immunology: Humira, the company's main product for many years, is increasingly being replaced by Skyrizi and Rinvoq. In oncology, Imbruvica, Venclexta and Elahere stand out, and in neuroscience, Vraylar, Ubrelvy, Qulipta and therapeutic Botox. The aesthetics business, added through the Allergan acquisition completed in 2020, includes Botox Cosmetic and Juvederm fillers.
Those following AbbVie stock track how far the decline in Humira due to biosimilar competition is being offset by newer products, clinical trial results, drug pricing regulation in the US and consumer demand for aesthetic products. The ABBV page on Lzzo.com presents the share price in US dollars with a historical chart and technical indicators; the source of the price and the time of the update are also included.
Sources: abbvie.com, investors.abbvie.com
- Name
- AbbVie Inc.
- Symbol
- ABBV
- Market
- Stocks
What to look for in the technical analysis of AbbVie Inc.
Moving averages help assess the trend and RSI helps assess momentum. Indicators are calculated from real history; when there is not enough history or the required candle fields are missing, the indicator is not calculated. Past results do not guarantee future performance.
Technical indicators
Calculated from observed daily candles (at least 201 observations). No intraday indicators. Indicators are descriptive, not a buy/sell recommendation.
Investment Return CalculatorWith observed closes over the past year
Loading historical prices…